Clinical Research Directory
Browse clinical research sites, groups, and studies.
GUARD-PH: Guided Use of AI-ECG for Risk Detection of PH in Surgery (GUARD-PH Trial)
Sponsor: Taipei Veterans General Hospital, Taiwan
Summary
This study is a prospective, open-label, randomized controlled trial designed to evaluate a new artificial intelligence (AI) tool for heart monitoring. Researchers will use an AI-enabled electrocardiography (ECG) system to screen patients before they undergo surgery. The main goal is to determine if this AI system can accurately detect pulmonary hypertension and related heart diseases in the preoperative setting. The study is being conducted at Taipei Veterans General Hospital.
Official title: A Prospective, Open-Label, Randomized Controlled Trial of an Artificial Intelligence Enabled Electrocardiography System for Preoperative Detection of Pulmonary Hypertension and Related Diseases(GUARD-PH)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1380
Start Date
2026-01-05
Completion Date
2027-01-05
Last Updated
2026-01-15
Healthy Volunteers
No
Conditions
Interventions
Artificial Intelligence-Enabled Electrocardiography System
The intervention involves using an artificial intelligence-enabled electrocardiography system to analyze standard ECGs for the preoperative detection of pulmonary hypertension.
Locations (1)
Taipei Veterans General Hospital
Taipei, Taiwan